
Episode 63
Biotech Hangout
00:00
The Importance of Precision Medicine in Oncology
Cura oncology had a 35 percent CR rate in NPM1 mutin AML. Editha's promoting some very high data like they had for patients in sickle cell disease. Vertex has an update with their sickle cell program that looked really strong. They announced their feedie debates both for sicklecell disease and beta thalassemia.
Transcript
Play full episode